Belgien - Englisch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

altan pharma ltd. - ropivacaine hydrochloride monohydrate 2 mg/ml - solution for infusion - 2 mg/ml - ropivacaine hydrochloride monohydrate 2 mg/ml - ropivacaine

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

mylan institutional llc - ropivacaine hydrochloride (unii: v910p86109) (ropivacaine - unii:7io5lya57n) - ropivacaine hydrochloride is indicated for the production of local or regional anesthesia for surgery and for acute pain management. acute pain management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration ropivacaine hydrochloride is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type.

Kanada - Englisch - Health Canada

pfizer canada ulc - ropivacaine hydrochloride - solution - 5mg - ropivacaine hydrochloride 5mg - local anesthetics

Kanada - Englisch - Health Canada

pfizer canada ulc - ropivacaine hydrochloride - solution - 10mg - ropivacaine hydrochloride 10mg - local anesthetics

Kanada - Englisch - Health Canada

pfizer canada ulc - ropivacaine hydrochloride - solution - 2mg - ropivacaine hydrochloride 2mg - local anesthetics

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

galen ltd - ropivacaine hydrochloride - solution for infusion - 2mg/1ml

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

actavis australia pty ltd - ropivacaine hydrochloride monohydrate; ropivacaine hydrochloride -

Israel - Englisch - Ministry of Health

propharm ltd - ropivacaine hydrochloride - solution for injection - ropivacaine hydrochloride 10 mg / 1 ml - ropivacaine - ropivacaine 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:surgical anaesthesia: lumbar epidural administration for surgery

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - ropivacaine hydrochloride 7.5 mg/ml equivalent to ropivacaine 6.64 mg/ml;   - solution for injection - 7.5 mg/ml - active: ropivacaine hydrochloride 7.5 mg/ml equivalent to ropivacaine 6.64 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - analgesia (adults and children over 12 years of age) · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain · field block (minor nerve block and infiltration) · continuous peripheral nerve block infusion or intermittent injections for postoperative pain management · continuous wound infusion for postoperative pain management (adults only) analgesia (children aged 0-12 years of age) · caudal epidural block in neonates (>37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years · continuous epidural infusion in infants (>30 days and over 2500 g weight) and children up to and including 12 years · peripheral nerve block in children aged 1 up to and including 12 years for peri- and postoperative pain management

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

general injectables & vaccines, inc - ropivacaine hydrochloride (unii: v910p86109) (ropivacaine - unii:7io5lya57n) - ropivacaine hydrochloride 5 mg in 1 ml - naropin is indicated for the production of local or regional anesthesia for surgery and for acute pain management. naropin is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type.